Tissue Quality of Integra vs. BTM Treated Burns
← catalyst calendarSponsored by Integra LifeSciences Corporation (industry) · IART — their whole pipeline →.
Phase
—
Status
Withdrawn
Study type
Observational
Enrollment
0actual
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Why the sponsor stopped it
change in company prioritizations
As filed on the registry record, in the sponsor's own words.
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-03-01 | actual | When the study began enrolling |
| Primary completion | 2025-09-30 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-09-30 | actual | The whole study's end, after follow-up |
| First posted | 2025-01-07 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-01-07 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Burn Injury
- Burn Scar
- Burn Wounds - Partial Thickness (2nd Degree)
- Skin Grafting
Primary outcomes
what the primary-completion date above is the date OFTime from Integra or BTM treated burns to autograft procedure
measured 12-36 months post final skin graft application
Vancouver Scar Scale assessment of tissue quality
measured 12-36 months post final skin graft application
Permalink · IART's whole pipeline · Catalyst calendar · Every registered study · What changed